Finance

Beta
Lists
NKTR:NASDAQ
Nektar Therapeutics
$61.79
-4.70%
(-3.05) 1D
Jun 25, 3:38:41 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NKTR...
Open
$65.04
High
$65.04
Low
$61.48
Mkt. cap
2.09B
Avg. vol.
934.76K
Volume
547.51K
52-wk high
$109.00
52-wk low
$21.02
EPS
-$8.42
Beta
1.13
Shares outstanding
33.79M
No. of employees
63
Open
$65.04
High
$65.04
Low
$61.48
Mkt. cap
2.09B
Avg. vol.
934.76K
Volume
547.51K
52-wk high
$109.00
52-wk low
$21.02
EPS
-$8.42
Beta
1.13
Shares outstanding
33.79M
No. of employees
63
News stories
From sources across the web
About Nektar Therapeutics
CEO-
Employees63
Founded1990
HeadquartersSan Francisco, California, United States
SectorPharmaceutical industry
Websitenektar.com
Analyst ratings
Based on 8 analysts giving stock ratings to NKTR in the past 3 months
Strong buy
Buy
7
Hold
1
Sell
0
12-month forecast
Based on 8 Wall Street analysts offering 12 month price targets for NKTR in the last 3 months.
Highest
Current $61.79
$192.00 (+210.73%)
Average
$154.33 (+149.77%)
Lowest
$80.00 (+29.47%)
Analyst
Recommendation
Action
Price target
Projected
Date
Samantha Semenkow
Citi
Buy
Maintained
$151.00
+144.4%
05/13/2026
Martin Fan
Wedbush
Hold
Maintained
$80.00
+29.5%
05/11/2026
Arthur He CFA
H.C. Wainwright
Buy
Maintained
$185.00
+199.4%
05/11/2026
Jay Olson
Oppenheimer
Buy
Maintained
$140.00
+126.6%
05/08/2026
Julian Harrison
BTIG
Buy
Maintained
$178.00
+188.1%
05/07/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
$192.00
+210.7%
05/08/2026
Marc Frahm
TD Cowen
Buy
Reiterated
-
-
05/08/2026
Andy Hsieh
William Blair
Buy
Reiterated
-
-
05/07/2026
Mayank Mamtani
B. Riley Securities
Buy
Maintained
$150.00
+142.8%
02/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
11.18M
11.79M
21.81M
10.86M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
29.89M
27.25M
29.71M
35.68M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.07M
16.07M
11.18M
13.44M
Operating expense
46.96M
43.32M
40.90M
49.12M
Total operating expenses
46.96M
43.32M
40.90M
49.12M
Operating income
-35.78M
-31.53M
-19.09M
-38.26M
Other non operating income
260.00K
-121.00K
-44.00K
-336.00K
EBT including unusual items
-41.78M
-35.56M
-36.05M
-44.84M
EBT excluding unusual items
-41.33M
-35.42M
-27.47M
-44.04M
Income tax expense
-188.00K
-33.00K
31.00K
64.00K
Effective tax rate
0.45%
0.09%
-0.09%
-0.14%
Other operating expenses
-
-
-
-
Net income
-41.59M
-35.52M
-36.08M
-44.90M
Net profit margin
-372.20%
-301.29%
-165.45%
-413.44%
Earnings per share
-2.78
-1.87
-1.29
-1.78
Interest and investment income
1.97M
2.82M
2.78M
4.24M
Interest expense
-5.39M
-6.05M
-9.77M
-7.94M
Net interest expenses
-3.42M
-3.23M
-6.99M
-3.70M
Depreciation and amortization charges
-
-
-
-
EBITDA
-35.57M
-31.34M
-18.90M
-38.11M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of NKTR
Explore what’s possible
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer